MovDisordV3, PascalFrancis, Corpus, bibRecord, 000D96

Parkinsonism in Gaucher's Disease Type 1: Ten New Cases and a Review of the Literature

Identifieur interne : 000D96 ( PascalFrancis/Corpus ); précédent : 000D95; suivant : 000D97

Parkinsonism in Gaucher's Disease Type 1: Ten New Cases and a Review of the Literature

Auteurs : Ichraf Kraoua ; Jérôme Stimemann ; Maria Joao Ribeiro ; Tiphaine Rouaud ; Marc Verin ; Agnès Annic ; Christian Rose ; Luc Defebvre ; Liliane Remenieras ; Mich L Schüpbach ; Nadia Belmatoug ; Marie Vidailhet ; Frédéric Sedel

Source :

Movement disorders [ 0885-3185 ] ; 2009.

RBID : Pascal:09-0358935

Descripteurs français

Pascal (Inist)
- Parkinsonisme, Sphingolipidose héréditaire de Gaucher, Maladie de Parkinson, Démence à corps de Lewy, Pathologie du système nerveux, Lipide.

English descriptors

KwdEn :
- Gaucher disease, Lewy body dementia, Lipids, Nervous system diseases, Parkinson disease, Parkinsonism.

Abstract

Parkinsonism has been described in patients with Gaucher's disease (GD). We reviewed the 10 cases of patients with both parkinsonism and GD recorded in the French national GD registry, as well as 49 previously published cases. Relative to the general population, parkinsonism in GD patients (1) was more frequent, (2) occurred at an earlier age, (3) responded less well to levodopa, and (4) was more frequently associated with signs of cortical dysfunction. Enzyme replacement therapy (ERT) and substrate reduction therapy (SRT) were ineffective on GD-associated parkinsonism, suggesting that parkinsonism itself is not an indication for ERT or SRT in this setting.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 24`
A06				`@2 10`
A08	`01`	`1`	`ENG`	`@1 Parkinsonism in Gaucher's Disease Type 1: Ten New Cases and a Review of the Literature`
A11	`01`	`1`		`@1 KRAOUA (Ichraf)`
A11	`02`	`1`		`@1 STIMEMANN (Jérôme)`
A11	`03`	`1`		`@1 RIBEIRO (Maria Joao)`
A11	`04`	`1`		`@1 ROUAUD (Tiphaine)`
A11	`05`	`1`		`@1 VERIN (Marc)`
A11	`06`	`1`		`@1 ANNIC (Agnès)`
A11	`07`	`1`		`@1 ROSE (Christian)`
A11	`08`	`1`		`@1 DEFEBVRE (Luc)`
A11	`09`	`1`		`@1 REMENIERAS (Liliane)`
A11	`10`	`1`		`@1 SCHÜPBACH (Michäl)`
A11	`11`	`1`		`@1 BELMATOUG (Nadia)`
A11	`12`	`1`		`@1 VIDAILHET (Marie)`
A11	`13`	`1`		`@1 SEDEL (Frédéric)`
A14	`01`			`@1 Federation of Nervous System Diseases, Reference Center for Lysosomal Diseases, Salpêtrière Hospital, ²Assistance Publique-Hôpitaux de Paris @3 FRA @Z 1 aut. @Z 10 aut. @Z 12 aut. @Z 13 aut.`
A14	`02`			`@1 Department of Internal Medicine, Jean Verdier Hospital, Assistance Publique-Hôpitaux de Paris, Paris XIII University @3 FRA @Z 2 aut.`
A14	`03`			`@1 Service Hospitalier Frédéric Joliot, I2BM, DSV, CEA @2 Orsay @3 FRA @Z 3 aut.`
A14	`04`			`@1 Department of Neurology, University Hospital of Rennes @2 Rennes @3 FRA @Z 4 aut. @Z 5 aut.`
A14	`05`			`@1 Department of Neurology, University Hospital of Lille @2 Lille @3 FRA @Z 6 aut. @Z 8 aut.`
A14	`06`			`@1 Department of Onco-Haematology, Saint Vincent de Paul Hospital @2 Lille @3 FRA @Z 7 aut.`
A14	`07`			`@1 Department of Haematology, University Hospitals of Limoges @2 Limoges @3 FRA @Z 9 aut.`
A14	`08`			`@1 Department of Internal Medicine, Reference Center for Lysosomal Diseases, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris @3 FRA @Z 11 aut.`
A14	`09`			`@1 INSERM U679, Pierre et Marie Curie (Paris 6) University @3 FRA @Z 12 aut.`
A20				`@1 1524-1530`
A21				`@1 2009`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000187543670150`
A44				`@0 0000 @1 © 2009 INIST-CNRS. All rights reserved.`
A45				`@0 32 ref.`
A47	`01`	`1`		`@0 09-0358935`
A60				`@1 P @3 CC`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Parkinsonism has been described in patients with Gaucher's disease (GD). We reviewed the 10 cases of patients with both parkinsonism and GD recorded in the French national GD registry, as well as 49 previously published cases. Relative to the general population, parkinsonism in GD patients (1) was more frequent, (2) occurred at an earlier age, (3) responded less well to levodopa, and (4) was more frequently associated with signs of cortical dysfunction. Enzyme replacement therapy (ERT) and substrate reduction therapy (SRT) were ineffective on GD-associated parkinsonism, suggesting that parkinsonism itself is not an indication for ERT or SRT in this setting.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Parkinsonisme @2 NM @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinsonism @2 NM @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson síndrome @2 NM @5 01`
C03	`02`	`X`	`FRE`	`@0 Sphingolipidose héréditaire de Gaucher @5 02`
C03	`02`	`X`	`ENG`	`@0 Gaucher disease @5 02`
C03	`02`	`X`	`SPA`	`@0 Esfingolipidosis hereditaria Gaucher @5 02`
C03	`03`	`X`	`FRE`	`@0 Maladie de Parkinson @2 NM @5 03`
C03	`03`	`X`	`ENG`	`@0 Parkinson disease @2 NM @5 03`
C03	`03`	`X`	`SPA`	`@0 Parkinson enfermedad @2 NM @5 03`
C03	`04`	`X`	`FRE`	`@0 Démence à corps de Lewy @2 NM @5 04`
C03	`04`	`X`	`ENG`	`@0 Lewy body dementia @2 NM @5 04`
C03	`04`	`X`	`SPA`	`@0 Demencia cuerpos Lewy @2 NM @5 04`
C03	`05`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 05`
C03	`05`	`X`	`ENG`	`@0 Nervous system diseases @5 05`
C03	`05`	`X`	`SPA`	`@0 Sistema nervioso patología @5 05`
C03	`06`	`X`	`FRE`	`@0 Lipide @5 78`
C03	`06`	`X`	`ENG`	`@0 Lipids @5 78`
C03	`06`	`X`	`SPA`	`@0 Lípido @5 78`
C07	`01`	`X`	`FRE`	`@0 Pathologie de l'encéphale @5 38`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 38`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 38`
C07	`02`	`X`	`FRE`	`@0 Enzymopathie @5 39`
C07	`02`	`X`	`ENG`	`@0 Enzymopathy @5 39`
C07	`02`	`X`	`SPA`	`@0 Enzimopatía @5 39`
C07	`03`	`X`	`FRE`	`@0 Lipoïdose @5 40`
C07	`03`	`X`	`ENG`	`@0 Lipoidosis @5 40`
C07	`03`	`X`	`SPA`	`@0 Lipoidosis @5 40`
C07	`04`	`X`	`FRE`	`@0 Maladie héréditaire @5 41`
C07	`04`	`X`	`ENG`	`@0 Genetic disease @5 41`
C07	`04`	`X`	`SPA`	`@0 Enfermedad hereditaria @5 41`
C07	`05`	`X`	`FRE`	`@0 Maladie métabolique @5 42`
C07	`05`	`X`	`ENG`	`@0 Metabolic diseases @5 42`
C07	`05`	`X`	`SPA`	`@0 Metabolismo patología @5 42`
C07	`06`	`X`	`FRE`	`@0 Pathologie du système nerveux central @5 43`
C07	`06`	`X`	`ENG`	`@0 Central nervous system disease @5 43`
C07	`06`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 43`
C07	`07`	`X`	`FRE`	`@0 Syndrome extrapyramidal @5 44`
C07	`07`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 44`
C07	`07`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 44`
C07	`08`	`X`	`FRE`	`@0 Maladie dégénérative @5 45`
C07	`08`	`X`	`ENG`	`@0 Degenerative disease @5 45`
C07	`08`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 45`
N21				`@1 257`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 09-0358935 INIST
ET :	Parkinsonism in Gaucher's Disease Type 1: Ten New Cases and a Review of the Literature
AU :	KRAOUA (Ichraf); STIMEMANN (Jérôme); RIBEIRO (Maria Joao); ROUAUD (Tiphaine); VERIN (Marc); ANNIC (Agnès); ROSE (Christian); DEFEBVRE (Luc); REMENIERAS (Liliane); SCHÜPBACH (Michäl); BELMATOUG (Nadia); VIDAILHET (Marie); SEDEL (Frédéric)
AF :	Federation of Nervous System Diseases, Reference Center for Lysosomal Diseases, Salpêtrière Hospital, ²Assistance Publique-Hôpitaux de Paris/France (1 aut., 10 aut., 12 aut., 13 aut.); Department of Internal Medicine, Jean Verdier Hospital, Assistance Publique-Hôpitaux de Paris, Paris XIII University/France (2 aut.); Service Hospitalier Frédéric Joliot, I2BM, DSV, CEA/Orsay/France (3 aut.); Department of Neurology, University Hospital of Rennes/Rennes/France (4 aut., 5 aut.); Department of Neurology, University Hospital of Lille/Lille/France (6 aut., 8 aut.); Department of Onco-Haematology, Saint Vincent de Paul Hospital/Lille/France (7 aut.); Department of Haematology, University Hospitals of Limoges/Limoges/France (9 aut.); Department of Internal Medicine, Reference Center for Lysosomal Diseases, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris/France (11 aut.); INSERM U679, Pierre et Marie Curie (Paris 6) University/France (12 aut.)
DT :	Publication en série; Courte communication, note brève; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2009; Vol. 24; No. 10; Pp. 1524-1530; Bibl. 32 ref.
LA :	Anglais
EA :	Parkinsonism has been described in patients with Gaucher's disease (GD). We reviewed the 10 cases of patients with both parkinsonism and GD recorded in the French national GD registry, as well as 49 previously published cases. Relative to the general population, parkinsonism in GD patients (1) was more frequent, (2) occurred at an earlier age, (3) responded less well to levodopa, and (4) was more frequently associated with signs of cortical dysfunction. Enzyme replacement therapy (ERT) and substrate reduction therapy (SRT) were ineffective on GD-associated parkinsonism, suggesting that parkinsonism itself is not an indication for ERT or SRT in this setting.
CC :	002B17; 002B17G
FD :	Parkinsonisme; Sphingolipidose héréditaire de Gaucher; Maladie de Parkinson; Démence à corps de Lewy; Pathologie du système nerveux; Lipide
FG :	Pathologie de l'encéphale; Enzymopathie; Lipoïdose; Maladie héréditaire; Maladie métabolique; Pathologie du système nerveux central; Syndrome extrapyramidal; Maladie dégénérative
ED :	Parkinsonism; Gaucher disease; Parkinson disease; Lewy body dementia; Nervous system diseases; Lipids
EG :	Cerebral disorder; Enzymopathy; Lipoidosis; Genetic disease; Metabolic diseases; Central nervous system disease; Extrapyramidal syndrome; Degenerative disease
SD :	Parkinson síndrome; Esfingolipidosis hereditaria Gaucher; Parkinson enfermedad; Demencia cuerpos Lewy; Sistema nervioso patología; Lípido
LO :	INIST-20953.354000187543670150
ID :	09-0358935

Links to Exploration step

Pascal:09-0358935

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Parkinsonism in Gaucher's Disease Type 1: Ten New Cases and a Review of the Literature</title>
<author><name sortKey="Kraoua, Ichraf" sort="Kraoua, Ichraf" uniqKey="Kraoua I" first="Ichraf" last="Kraoua">Ichraf Kraoua</name>
<affiliation><inist:fA14 i1="01"><s1>Federation of Nervous System Diseases, Reference Center for Lysosomal Diseases, Salpêtrière Hospital, <sup>2 </sup>
Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stimemann, Jerome" sort="Stimemann, Jerome" uniqKey="Stimemann J" first="Jérôme" last="Stimemann">Jérôme Stimemann</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Internal Medicine, Jean Verdier Hospital, Assistance Publique-Hôpitaux de Paris, Paris XIII University</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ribeiro, Maria Joao" sort="Ribeiro, Maria Joao" uniqKey="Ribeiro M" first="Maria Joao" last="Ribeiro">Maria Joao Ribeiro</name>
<affiliation><inist:fA14 i1="03"><s1>Service Hospitalier Frédéric Joliot, I2BM, DSV, CEA</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rouaud, Tiphaine" sort="Rouaud, Tiphaine" uniqKey="Rouaud T" first="Tiphaine" last="Rouaud">Tiphaine Rouaud</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Neurology, University Hospital of Rennes</s1>
<s2>Rennes</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Verin, Marc" sort="Verin, Marc" uniqKey="Verin M" first="Marc" last="Verin">Marc Verin</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Neurology, University Hospital of Rennes</s1>
<s2>Rennes</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Annic, Agnes" sort="Annic, Agnes" uniqKey="Annic A" first="Agnès" last="Annic">Agnès Annic</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Neurology, University Hospital of Lille</s1>
<s2>Lille</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rose, Christian" sort="Rose, Christian" uniqKey="Rose C" first="Christian" last="Rose">Christian Rose</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Onco-Haematology, Saint Vincent de Paul Hospital</s1>
<s2>Lille</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Defebvre, Luc" sort="Defebvre, Luc" uniqKey="Defebvre L" first="Luc" last="Defebvre">Luc Defebvre</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Neurology, University Hospital of Lille</s1>
<s2>Lille</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Remenieras, Liliane" sort="Remenieras, Liliane" uniqKey="Remenieras L" first="Liliane" last="Remenieras">Liliane Remenieras</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Haematology, University Hospitals of Limoges</s1>
<s2>Limoges</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schupbach, Mich L" sort="Schupbach, Mich L" uniqKey="Schupbach M" first="Mich L" last="Schüpbach">Mich L Schüpbach</name>
<affiliation><inist:fA14 i1="01"><s1>Federation of Nervous System Diseases, Reference Center for Lysosomal Diseases, Salpêtrière Hospital, <sup>2 </sup>
Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Belmatoug, Nadia" sort="Belmatoug, Nadia" uniqKey="Belmatoug N" first="Nadia" last="Belmatoug">Nadia Belmatoug</name>
<affiliation><inist:fA14 i1="08"><s1>Department of Internal Medicine, Reference Center for Lysosomal Diseases, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation><inist:fA14 i1="01"><s1>Federation of Nervous System Diseases, Reference Center for Lysosomal Diseases, Salpêtrière Hospital, <sup>2 </sup>
Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="09"><s1>INSERM U679, Pierre et Marie Curie (Paris 6) University</s1>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sedel, Frederic" sort="Sedel, Frederic" uniqKey="Sedel F" first="Frédéric" last="Sedel">Frédéric Sedel</name>
<affiliation><inist:fA14 i1="01"><s1>Federation of Nervous System Diseases, Reference Center for Lysosomal Diseases, Salpêtrière Hospital, <sup>2 </sup>
Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0358935</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 09-0358935 INIST</idno>
<idno type="RBID">Pascal:09-0358935</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D96</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Parkinsonism in Gaucher's Disease Type 1: Ten New Cases and a Review of the Literature</title>
<author><name sortKey="Kraoua, Ichraf" sort="Kraoua, Ichraf" uniqKey="Kraoua I" first="Ichraf" last="Kraoua">Ichraf Kraoua</name>
<affiliation><inist:fA14 i1="01"><s1>Federation of Nervous System Diseases, Reference Center for Lysosomal Diseases, Salpêtrière Hospital, <sup>2 </sup>
Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stimemann, Jerome" sort="Stimemann, Jerome" uniqKey="Stimemann J" first="Jérôme" last="Stimemann">Jérôme Stimemann</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Internal Medicine, Jean Verdier Hospital, Assistance Publique-Hôpitaux de Paris, Paris XIII University</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ribeiro, Maria Joao" sort="Ribeiro, Maria Joao" uniqKey="Ribeiro M" first="Maria Joao" last="Ribeiro">Maria Joao Ribeiro</name>
<affiliation><inist:fA14 i1="03"><s1>Service Hospitalier Frédéric Joliot, I2BM, DSV, CEA</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rouaud, Tiphaine" sort="Rouaud, Tiphaine" uniqKey="Rouaud T" first="Tiphaine" last="Rouaud">Tiphaine Rouaud</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Neurology, University Hospital of Rennes</s1>
<s2>Rennes</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Verin, Marc" sort="Verin, Marc" uniqKey="Verin M" first="Marc" last="Verin">Marc Verin</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Neurology, University Hospital of Rennes</s1>
<s2>Rennes</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Annic, Agnes" sort="Annic, Agnes" uniqKey="Annic A" first="Agnès" last="Annic">Agnès Annic</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Neurology, University Hospital of Lille</s1>
<s2>Lille</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rose, Christian" sort="Rose, Christian" uniqKey="Rose C" first="Christian" last="Rose">Christian Rose</name>
<affiliation><inist:fA14 i1="06"><s1>Department of Onco-Haematology, Saint Vincent de Paul Hospital</s1>
<s2>Lille</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Defebvre, Luc" sort="Defebvre, Luc" uniqKey="Defebvre L" first="Luc" last="Defebvre">Luc Defebvre</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Neurology, University Hospital of Lille</s1>
<s2>Lille</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Remenieras, Liliane" sort="Remenieras, Liliane" uniqKey="Remenieras L" first="Liliane" last="Remenieras">Liliane Remenieras</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Haematology, University Hospitals of Limoges</s1>
<s2>Limoges</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schupbach, Mich L" sort="Schupbach, Mich L" uniqKey="Schupbach M" first="Mich L" last="Schüpbach">Mich L Schüpbach</name>
<affiliation><inist:fA14 i1="01"><s1>Federation of Nervous System Diseases, Reference Center for Lysosomal Diseases, Salpêtrière Hospital, <sup>2 </sup>
Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Belmatoug, Nadia" sort="Belmatoug, Nadia" uniqKey="Belmatoug N" first="Nadia" last="Belmatoug">Nadia Belmatoug</name>
<affiliation><inist:fA14 i1="08"><s1>Department of Internal Medicine, Reference Center for Lysosomal Diseases, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation><inist:fA14 i1="01"><s1>Federation of Nervous System Diseases, Reference Center for Lysosomal Diseases, Salpêtrière Hospital, <sup>2 </sup>
Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="09"><s1>INSERM U679, Pierre et Marie Curie (Paris 6) University</s1>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sedel, Frederic" sort="Sedel, Frederic" uniqKey="Sedel F" first="Frédéric" last="Sedel">Frédéric Sedel</name>
<affiliation><inist:fA14 i1="01"><s1>Federation of Nervous System Diseases, Reference Center for Lysosomal Diseases, Salpêtrière Hospital, <sup>2 </sup>
Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Gaucher disease</term>
<term>Lewy body dementia</term>
<term>Lipids</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Parkinsonism</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinsonisme</term>
<term>Sphingolipidose héréditaire de Gaucher</term>
<term>Maladie de Parkinson</term>
<term>Démence à corps de Lewy</term>
<term>Pathologie du   système nerveux</term>
<term>Lipide</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Parkinsonism has been described in patients with Gaucher's disease (GD). We reviewed the 10 cases of patients with both parkinsonism and GD recorded in the French national GD registry, as well as 49 previously published cases. Relative to the general population, parkinsonism in GD patients (1) was more frequent, (2) occurred at an earlier age, (3) responded less well to levodopa, and (4) was more frequently associated with signs of cortical dysfunction. Enzyme replacement therapy (ERT) and substrate reduction therapy (SRT) were ineffective on GD-associated parkinsonism, suggesting that parkinsonism itself is not an indication for ERT or SRT in this setting.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>24</s2>
</fA05>
<fA06><s2>10</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Parkinsonism in Gaucher's Disease Type 1: Ten New Cases and a Review of the Literature</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>KRAOUA (Ichraf)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>STIMEMANN (Jérôme)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>RIBEIRO (Maria Joao)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>ROUAUD (Tiphaine)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>VERIN (Marc)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>ANNIC (Agnès)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>ROSE (Christian)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>DEFEBVRE (Luc)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>REMENIERAS (Liliane)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>SCHÜPBACH (Michäl)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>BELMATOUG (Nadia)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>VIDAILHET (Marie)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>SEDEL (Frédéric)</s1>
</fA11>
<fA14 i1="01"><s1>Federation of Nervous System Diseases, Reference Center for Lysosomal Diseases, Salpêtrière Hospital, <sup>2 </sup>
Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Internal Medicine, Jean Verdier Hospital, Assistance Publique-Hôpitaux de Paris, Paris XIII University</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Service Hospitalier Frédéric Joliot, I2BM, DSV, CEA</s1>
<s2>Orsay</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Neurology, University Hospital of Rennes</s1>
<s2>Rennes</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Neurology, University Hospital of Lille</s1>
<s2>Lille</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Department of Onco-Haematology, Saint Vincent de Paul Hospital</s1>
<s2>Lille</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Department of Haematology, University Hospitals of Limoges</s1>
<s2>Limoges</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Department of Internal Medicine, Reference Center for Lysosomal Diseases, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris</s1>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>INSERM U679, Pierre et Marie Curie (Paris 6) University</s1>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA20><s1>1524-1530</s1>
</fA20>
<fA21><s1>2009</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000187543670150</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>32 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>09-0358935</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Parkinsonism has been described in patients with Gaucher's disease (GD). We reviewed the 10 cases of patients with both parkinsonism and GD recorded in the French national GD registry, as well as 49 previously published cases. Relative to the general population, parkinsonism in GD patients (1) was more frequent, (2) occurred at an earlier age, (3) responded less well to levodopa, and (4) was more frequently associated with signs of cortical dysfunction. Enzyme replacement therapy (ERT) and substrate reduction therapy (SRT) were ineffective on GD-associated parkinsonism, suggesting that parkinsonism itself is not an indication for ERT or SRT in this setting.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinsonisme</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinsonism</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson síndrome</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Sphingolipidose héréditaire de Gaucher</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Gaucher disease</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Esfingolipidosis hereditaria Gaucher</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Démence à corps de Lewy</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Lewy body dementia</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Demencia cuerpos Lewy</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Lipide</s0>
<s5>78</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Lipids</s0>
<s5>78</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Lípido</s0>
<s5>78</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>38</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>38</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Enzymopathie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Enzymopathy</s0>
<s5>39</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Enzimopatía</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Lipoïdose</s0>
<s5>40</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Lipoidosis</s0>
<s5>40</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Lipoidosis</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Maladie héréditaire</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Genetic disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Enfermedad hereditaria</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie métabolique</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Metabolic diseases</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Metabolismo patología</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Pathologie du   système nerveux central</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>44</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>44</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>44</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>45</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>45</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>45</s5>
</fC07>
<fN21><s1>257</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 09-0358935 INIST</NO>
<ET>Parkinsonism in Gaucher's Disease Type 1: Ten New Cases and a Review of the Literature</ET>
<AU>KRAOUA (Ichraf); STIMEMANN (Jérôme); RIBEIRO (Maria Joao); ROUAUD (Tiphaine); VERIN (Marc); ANNIC (Agnès); ROSE (Christian); DEFEBVRE (Luc); REMENIERAS (Liliane); SCHÜPBACH (Michäl); BELMATOUG (Nadia); VIDAILHET (Marie); SEDEL (Frédéric)</AU>
<AF>Federation of Nervous System Diseases, Reference Center for Lysosomal Diseases, Salpêtrière Hospital, <sup>2 </sup>
Assistance Publique-Hôpitaux de Paris/France (1 aut., 10 aut., 12 aut., 13 aut.); Department of Internal Medicine, Jean Verdier Hospital, Assistance Publique-Hôpitaux de Paris, Paris XIII University/France (2 aut.); Service Hospitalier Frédéric Joliot, I2BM, DSV, CEA/Orsay/France (3 aut.); Department of Neurology, University Hospital of Rennes/Rennes/France (4 aut., 5 aut.); Department of Neurology, University Hospital of Lille/Lille/France (6 aut., 8 aut.); Department of Onco-Haematology, Saint Vincent de Paul Hospital/Lille/France (7 aut.); Department of Haematology, University Hospitals of Limoges/Limoges/France (9 aut.); Department of Internal Medicine, Reference Center for Lysosomal Diseases, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris/France (11 aut.); INSERM U679, Pierre et Marie Curie (Paris 6) University/France (12 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2009; Vol. 24; No. 10; Pp. 1524-1530; Bibl. 32 ref.</SO>
<LA>Anglais</LA>
<EA>Parkinsonism has been described in patients with Gaucher's disease (GD). We reviewed the 10 cases of patients with both parkinsonism and GD recorded in the French national GD registry, as well as 49 previously published cases. Relative to the general population, parkinsonism in GD patients (1) was more frequent, (2) occurred at an earlier age, (3) responded less well to levodopa, and (4) was more frequently associated with signs of cortical dysfunction. Enzyme replacement therapy (ERT) and substrate reduction therapy (SRT) were ineffective on GD-associated parkinsonism, suggesting that parkinsonism itself is not an indication for ERT or SRT in this setting.</EA>
<CC>002B17; 002B17G</CC>
<FD>Parkinsonisme; Sphingolipidose héréditaire de Gaucher; Maladie de Parkinson; Démence à corps de Lewy; Pathologie du   système nerveux; Lipide</FD>
<FG>Pathologie de l'encéphale; Enzymopathie; Lipoïdose; Maladie héréditaire; Maladie métabolique; Pathologie du système nerveux central; Syndrome extrapyramidal; Maladie dégénérative</FG>
<ED>Parkinsonism; Gaucher disease; Parkinson disease; Lewy body dementia; Nervous system diseases; Lipids</ED>
<EG>Cerebral disorder; Enzymopathy; Lipoidosis; Genetic disease; Metabolic diseases; Central nervous system disease; Extrapyramidal syndrome; Degenerative disease</EG>
<SD>Parkinson síndrome; Esfingolipidosis hereditaria Gaucher; Parkinson enfermedad; Demencia cuerpos Lewy; Sistema nervioso patología; Lípido</SD>
<LO>INIST-20953.354000187543670150</LO>
<ID>09-0358935</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D96 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000D96 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:09-0358935
   |texte=   Parkinsonism in Gaucher's Disease Type 1: Ten New Cases and a Review of the Literature
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Parkinsonism in Gaucher's Disease Type 1: Ten New Cases and a Review of the Literature

Parkinsonism in Gaucher's Disease Type 1: Ten New Cases and a Review of the Literature

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri